|
|
|
|
L-018 / L-018-1ML updated item number format
Lidocaine
1.0 mg/mL in Methanol | Certified Reference Material
|
|
Lidocaine is a local anesthetic and antiarrhythmic drug. This analytical reference standard is suitable for use in LC/MS or GC/MS applications for urine drug testing, clinical toxicology, and forensic analysis. Lidocaine is often added to cocaine as a diluent.
|
|
|
|
|
| Concentration:
|
1.0 mg/mL
|
| Solvent:
|
Methanol
|
| Unit Size:
|
1 mL/ampoule
|
| CAS Number:
|
137-58-6
|
| Chemical Formula:
|
C14H22N2O
|
| Molecular Weight:
|
234.34
|
| Certificate of Analysis:
|
|
| US List Price:
|
|
|
|
UN Number, Class, PG
1230, 3, II
Safety Data Sheet
HS Code
3822.90.0000
|
▶ CESI-MS Analysis of Biofluids of Basic Drugs and Metabolites | John C. Hudson, Beckman Coulter Inc., 2012
|
|
▶ Comparison of Forensic Tandem Mass Spectral Data Obtained on Portable Instrumentation to an Established Reference Library | Adam E. O’Leary, Seth E. Hall, Herbert M. Oberacher, andChristopher C. Mulligan, llinois State University Department of Chemistry, 2014
|
|
▶ Investigating Matrix Interference in Analysis of Antiarrhythmic Cardiac Drugs in Plasma | Supelco, 2013
|
|
▶ LC/MS (TOF) Analysis of Antiarrhythmic Drugs and Metabolites in Plasma on Ascentis® Express 2.7 µm HILIC after Sample Prep using HybridSPE®-Phospholipid | Sigma-Aldrich®, 2014
|
|
▶ LC/MS (TOF) Analysis of Antiarrhythmic Drugs and Metabolites in Plasma on Ascentis® Express 2.7 µm HILIC: Improvement in Analyte Response after Solid Phase Extraction (SPE) using HybridSPE®-Phospholipid The basic characteristics of antiarrhythmic cardiac drugs and associated | Sigma-Aldrich®, 2014
|
|
▶ LC/MS (TOF) Analysis of Antiarrhythmic Drugs and Metabolites on Ascentis® Express 2.7 µm HILIC | Sigma-Aldrich®, 2014
|
|
|
|
|